Henry Schein, Inc.

Henry Schein, Inc. is a global provider of healthcare products and services, headquartered in Melville, New York, U.S.. The company's mission is to provide innovative, integrated healthcare products and services, and to serve as trusted advisors and consultants to its customers, enabling them to deliver quality patient care and enhance practice management efficiency and profitability.

The company specializes in the distribution of medical and dental supplies, including vaccines, pharmaceuticals, financial services, and equipment. Henry Schein serves office-based dental and medical practitioners, as well as dental laboratories, government and institutional healthcare clinics, and other alternate care sites. Its offerings span Global Distribution, Global Specialty Products, and Global Technology segments, encompassing practice management software like Dentrix Ascend, digital imaging systems, and a wide array of supplies for dental, medical, and animal health sectors.

Frederick M. Lowery was appointed as the new Chief Executive Officer, effective March 2, 2026, succeeding Stanley M. Bergman, who transitioned to Chairman of the Board after 35 years in the CEO role. Henry Schein is recognized as the world's largest provider of healthcare solutions to office-based dental and medical practitioners. A Fortune 500 company and a member of the S&P 500 index, Henry Schein reported sales of $13.2 billion in 2025. Recent developments include the election of William K. Daniel as Independent Chairman of the Board in May 2026 and the release of the 2026 Catalyst Index by Henry Schein One, which highlighted clinical performance as a key driver of growth. The company continues to focus on investments in digital ordering, e-commerce tools, and integrated supply chain systems.